Bashir Ahmad
Impact in
- Pharmacology top 10%
-
- Phytochemicals and Antioxidant Activities
Papers in
-
- Natural product bioactivities and synthesis 9
- Genomics, phytochemicals, and oxidative stress 4
- Ubiquitin and proteasome pathways 3
-
- Phytochemistry and Biological Activities 4
- Co-authors
- Sadiq Azam (5 shared papers)Manzoor Ahmad (4 shared papers)Shumaila Bashir (4 shared papers)Suliman Khan (1 shared paper)Mengzhou Xue (1 shared paper)Sunjeet Kumar (1 shared paper)Ghulam Nabi (1 shared paper)Yang Liu (1 shared paper)
In The Last Decade
Bashir Ahmad
39 papers receiving 428 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 53
- Biochemistry 33
- Complementary and alternative medicine 38
- Toxicology 15
- Endocrinology, Diabetes and Metabolism 69
Countries citing papers authored by Bashir Ahmad
This map shows the geographic impact of Bashir Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bashir Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bashir Ahmad more than expected).
Fields of papers citing papers by Bashir Ahmad
This network shows the impact of papers produced by Bashir Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bashir Ahmad. The network helps show where Bashir Ahmad may publish in the future.
Co-authors
The 25 scholars most cited alongside Bashir Ahmad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 61 | |
| 2 | 2020 | 28 | |
| 3 | 2020 | 26 | |
| 4 | 1995 | 26 | |
| 5 | 2003 | 23 | |
| 6 | 2020 | 20 | |
| 7 | 2011 | 20 | |
| 8 | 2021 | 19 | |
| 9 | 2020 | 19 | |
| 10 | 2021 | 18 | |
| 11 | 2021 | 18 | |
| 12 | 2017 | 16 | |
| 13 | 2011 | 16 | |
| 14 | 2009 | 16 | |
| 15 | 2016 | 16 | |
| 16 | 2020 | 16 | |
| 17 | 2024 | 13 | |
| 18 | 2021 | 8 | |
| 19 | Pharmacogenomic approaches in the treatment of breast cancer by tamoxifen. | 2012 | 8 |
| 20 | Alantolactone enhances Cisplatin anticancer activity in A549 cells through inhibition of STAT3 activation and mitochondrial dependent pathway | 2020 | 7 |
About Bashir Ahmad
Bashir Ahmad is a scholar working on Molecular Biology, Plant Science, Oncology, Pharmacology and Pharmacology, having authored 40 papers that have together received 456 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (9 papers), Natural Antidiabetic Agents Studies (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Phytochemistry and Biological Activities (4 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Phytochemicals and Antioxidant Activities (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Pharmacology (53 citations), Biochemistry (33 citations), Complementary and alternative medicine (38 citations), Toxicology (15 citations) and Endocrinology, Diabetes and Metabolism (69 citations). Bashir Ahmad has collaborated with scholars based in Pakistan, China and Egypt. Frequent co-authors include Sadiq Azam, Manzoor Ahmad, Shumaila Bashir, Suliman Khan, Mengzhou Xue, Sunjeet Kumar, Ghulam Nabi, Yang Liu, Kun Zou and Lijuan Zou. Their work appears in journals such as OncoTargets and Therapy, PLoS ONE, Journal of Cellular Physiology, npj Precision Oncology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.